Folic Acid
Adenoma
US Department of Veterans AffairsSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Adenoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
r-5780 Rise Therapeutics LLC | Phase 1 | CC |
S-Adenosyl-L-Methionine Jun Gong, MD | Phase 1 | CC |
Eovist Bayer | D | |
BAY-86-4873 Bayer | D |
Same molecule, other indications
Folic Acid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →